Self-renewal of hematopoietic and leukemic stem cells: A central role for the Polycomb-group gene Bmi-1

Trends in Immunology

Volumn 24, Issue 10, 2003, Pages 522-524

  Raaphorst, Frank M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE;

BLOOD CELL; CELL ACTIVITY; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; GENE FUNCTION; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; NONHUMAN; REGULATOR GENE; SHORT SURVEY; STEM CELL;

EID: 0141670822     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00241-2     Document Type: Short Survey

References (24)

1. Park I.K., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:2003;302-305.
2. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:2003;255-260.
3. Raaphorst F.M., et al. Polycomb-group genes as regulators of mammalian lymphopoiesis. Trends Immunol. 22:2001;682-690.
4. Muyrers-Chen I., Paro R. Epigenetics: unforeseen regulators in cancer. Biochim. Biophys. Acta. 1552:2001;15-26.
5. Jacobs J.J., van Lohuizen M. Cellular memory of transcriptional states by Polycomb-group proteins. Semin. Cell Dev. Biol. 10:1999;227-235.
6. Satijn D.P., Otte A.P. Polycomb group protein complexes: do different complexes regulate distinct target genes? Biochim. Biophys. Acta. 1447:1999;1-16.
7. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell. 112:2003;599-606.
8. Park I.K., et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 99:2002;488-498.
9. Lessard J., et al. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood. 91:1998;1216-1224.
10. van der Lugt N.M., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8:1994;757-769.
11. Jacobs J.J., et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:1999;164-168.
12. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111.
13. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:1997;730-737.
14. Kroon E., et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:1998;3714-3725.
15. Akasaka T.K., et al. The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity. 7:1997;135-146.
16. Tokimasa S., et al. Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage. Exp. Hematol. 29:2001;93-103.
17. Kimura M., et al. Regulation of Th2 cell differentiation by mel-18, a mammalian Polycomb group gene. Immunity. 15:2001;275-287.
18. Su I.H., et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4:2003;124-131.
19. Dimri G.P., et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62:2002;4736-4745.
20. Raaphorst F.M., et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol. 157:2000;709-715.
21. van Kemenade F.J., et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 97:2001;3896-3901.
22. Varambally S., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:2002;624-629.
23. Vonlanthen S., et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer. 84:2001;1372-1376.
24. Al Hajj M., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3983-3988.